Skip to main content
Clinical Trials/ISRCTN17267090
ISRCTN17267090
Completed
未知

International Neonatal tranSfusion PoInt pREvalence study

eiden University Medical Center0 sites1,143 target enrollmentDecember 2, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
The use of blood transfusion in European preterm infants
Sponsor
eiden University Medical Center
Enrollment
1143
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 2, 2022
End Date
September 30, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • A potential subject who meets both of the following criteria can be included in this study:
  • 1\. Admission to a participating tertiary level NICU during the study period (note: this also includes neonates who are admitted to the NICU prior to the start of the study period, born outside the NICU institute of admission and/or readmitted to the NICU)
  • 2\. Gestational age at birth below 32 weeks (note: the postmenstrual age \[PMA; gestational age \+ chronological age] at admission can be \=32\+0 weeks, however the PMA at inclusion cannot exceed 44\+0 weeks)

Exclusion Criteria

  • Does not meet the inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials